Publications by authors named "T P Hanna"
Rationale And Objectives: To evaluate radiologists' perspectives regarding American Medical Association Category 1 Continuing Medical Education (Cat-1 CME) activities in private practice (PP) and teleradiology (TR), as well as American Board of Radiology Maintenance of Certification (ABR MOC) program participation status.
Materials And Methods: An electronic survey informed by existing literature regarding physician Cat-1 CME use and opinions was distributed via email to a national radiology practice. The survey was open for seventeen days in 2023, with a single reminder.
Health care system factors associated with receipt of treatment and treatment intent in stage III non-small cell lung cancer: A population-based study in Ontario.
Clin Transl Radiat Oncol
January 2025
Purpose: Stage III non-small cell lung cancer (NSCLC) is a heterogeneous disease, with a spectrum of anatomic extent, health status, and treatment approaches. Receipt of treatment and its intent should be independent of health system factors where care quality is optimal. We investigated the degree that modifiable health system factors are associated with receipt of treatment and treatment intent in stage III NSCLC in a large, universal health system.
View Article and Find Full Text PDFArticle Synopsis
- Understanding future dynamics in human and natural development is crucial for creating effective policies to tackle global challenges.
- A protocol is provided for integrating external data into the International Futures (IFs) model, focusing on key variables like socioeconomic pathways.
- The protocol includes steps for installing necessary software, importing data, running the model, and extracting results, with more detailed guidance available in Moyer's work.
Article Synopsis
- * They used a retrospective design to match patients receiving the multi-gene test to those undergoing single-gene testing, focusing on survival outcomes and costs from a healthcare payer's perspective.
- * Results showed that multi-gene panel testing had longer turnaround times and slightly increased costs, but it also resulted in marginally better survival rates; however, the overall net monetary benefit was inconclusive, with varying cost-effectiveness results across multiple scenarios.
Importance: Cancer and its care impose significant time commitments on patients and care partners. The oncology community has only recently conceptualized these commitments and the associated burden as the "time toxicity" of cancer care. As the concept gains traction, there is a critical need to fundamentally understand the perspectives of multiple stakeholders on the time burdens of cancer care.
View Article and Find Full Text PDF